Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Jodendom en vroeg christendom: continuïteit en discontinuïteit T. Baarda H. J. de Jonge M. J. J. Menken

Autor: van der Woude, A. S.

Publikováno v: Journal for the Study of Judaism in the Persian, Hellenistic, and Roman Period, 1991 Dec 01. 22(2), 254-255.

Externí odkaz: https://www.jstor.org/stable/24660049

Electroconvulsive Therapy Versus Aripiprazole Addition to Clozapine in Patients with Clozapine-Resistant Symptoms (EMECLO): A Protocol of a Single-Blind, Multicenter, Randomized-Controlled Feasibility Trial.

Autor: den Toom M; Department of Psychiatry, Amsterdam UMC, The Netherlands., Blanken L; Department of Psychiatry, Amsterdam UMC, The Netherlands.; Department of Psychiatry, Dijklander Ziekenhuis, Hoorn, Netherlands., Horn I; MS centrum, Amsterdam UMC, The Netherlands., Veerman S; Mental Health Service Noord Holland Noord, The Netherlands., van der Vlugt-Molenaar JJB; Antes - Parnassia Group, Rotterdam, The Netherlands., de Koning MB; Arkin Mental Health Care, Amsterdam, The Netherlands., Bogers J; Mental Health Service Rivierduinen, High Care Clinics and Rivierduinen Academy, Leiden, The Netherlands., Enterman J; Parnassia, The Hague, The Netherlands., de Jonge M; Pro Persona, Arnhem, The Netherlands., Cianci D; Department of Psychiatry, UMC Utrecht Brain Center., Frederix GWJ; Mental Health Service Noord Holland Noord, The Netherlands., de Haas HJ; Department of Psychiatry, Amsterdam UMC, The Netherlands.; Arkin Mental Health Care, Amsterdam, The Netherlands., Storosum BW; Department of Psychiatry, Amsterdam UMC, The Netherlands., Veereschild M; GGNet Mental Health, Warnsveld, The Netherlands., Javadzadeh M; GGNet Mental Health, Warnsveld, The Netherlands., Schulte PFJ; Mental Health Service Noord Holland Noord, The Netherlands., Cohen D; Mental Health Service Noord Holland Noord, The Netherlands., van Os J; Department of Psychiatry, UMC Utrecht Brain Center., Cahn W; Department of Psychiatry, UMC Utrecht Brain Center., de Haan L; Department of Psychiatry, Amsterdam UMC, The Netherlands.; Arkin Mental Health Care, Amsterdam, The Netherlands., Zantvoord JB; Department of Psychiatry, Amsterdam UMC, The Netherlands., Luykx JJ; Department of Psychiatry, Amsterdam UMC, The Netherlands.; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands.; GGZ InGeest Mental Health Care, Amsterdam, The Netherlands.

Publikováno v: Pharmacopsychiatry [Pharmacopsychiatry] 2024 Nov; Vol. 57 (6), pp. 290-295. Date of Electronic Publication: 2024 Aug 26.

Capmatinib in MET exon 14-mutated non-small-cell lung cancer: final results from the open-label, phase 2 GEOMETRY mono-1 trial.

Autor: Wolf J; Department of Internal Medicine, Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany. Electronic address: juergen.wolf@uk-koeln.de., Hochmair M; Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Department of Respiratory and Critical Care Medicine, Krankenhaus Nord, Klinik Floridsdorf, Vienna, Austria., Han JY; National Cancer Center, Goyang, South Korea., Reguart N; Medical Oncology Department, Hospital Clínic i Provincial de Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapeutics in Solid Tumours, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Souquet PJ; Department of Thoracic Oncology, CH Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France., Smit EF; Department of Pulmonary Diseases, Leiden University Medical Center, Leiden, Netherlands., Orlov SV; Department of Thoracic Oncology, St Petersburg State Medical University, St Petersburg, Russia., Vansteenkiste J; Respiratory Oncology Unit, University Hospital KU Leuven, Leuven, Belgium., Nishio M; Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan., de Jonge M; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands., Akerley W; Huntsman Cancer Institute, Salt Lake City, UT, USA; Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA., Garon EB; David Geffen School of Medicine, UCLA, Los Angeles, CA, USA., Groen HJM; Department of Pulmonary Diseases, University Medical Center Groningen and University of Groningen, Groningen, Netherlands., Tan DSW; Department of Medical Oncology, National Cancer Centre Singapore, Singapore., Seto T; NHO Kyushu Cancer Center, Fukuoka, Japan., Frampton GM; Foundation Medicine, Boston, MA, USA., Robeva A; Oncology Global Drug Development, Novartis Pharmaceuticals, East Hanover, NJ, USA., Carbini M; Oncology DU Global Drug Development, Novartis Pharma, Basel, Switzerland., Le Mouhaer S; Global Drug Development, Novartis Pharma S.A.S, Rueil Malmaison, France., Yovine A; Oncology DU Global Drug Development, Novartis Pharma, Basel, Switzerland., Boran A; Global Drug Development, Novartis Services, East Hanover, New Jersey, USA., Bossen C; Oncology DU Global Drug Development, Novartis Pharma, Basel, Switzerland., Yang Y; Oncology Global Drug Development, Novartis Pharmaceuticals, East Hanover, NJ, USA., Ji L; Oncology Data Science, Novartis BioMedical Research, Cambridge, MA, USA., Fairchild L; Oncology Data Science, Novartis BioMedical Research, Cambridge, MA, USA., Heist RS; Department of Medical Oncology, Massachusetts General Hospital, Boston, MA, USA.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2024 Oct; Vol. 25 (10), pp. 1357-1370.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.